Posted: September 13th, 2017

INTRODUCTION;

WEEK 5 INTRODUCTION;
WEEKLY SUMMARY
Last week you were introduced to health financing. You explored mechanisms, objectives, and activities of health financing. Implicit and explicit priority-setting approaches were discussed. The aim of this week is to introduce you to economic evaluations. The main types of economic evaluation will be explained in this session. You will calculate and interpret incremental cost-effectiveness ratios as well as apply simple forms of discounting. The main approaches of sensitivity analysis will be explained.

WEEK 5 ASSIGNMENT:

HAND-IN ASSIGNMENT
•    Briefly explain the concept of incremental cost-effectiveness ratio (ICER).
•    Using the data below, calculate the average and incremental ICERs. Assume that the options are mutually exclusive. Hint: Sort options according to cost.
•    Comment about the dominance of Beclomethasone over Salmeterol-high dose.
•    Indicate your choice when the 3-month budget is USD 200 and USD 300.
•    If Ipratropium treatment is the existing one, and if your incremental threshold ratio is USD 500 per FEV1 unit, what are the feasible options?
Cost (USD) over 3-month study period    Change in FEV1 (l)
Placebo    60.00    1.1
Salmeterol: low dose    170.00    1.5
Salmeterol: high dose    360.00    1.6
Ipratropium    90.00    1.3
Beclomethasone    280.00    1.7